共查询到20条相似文献,搜索用时 15 毫秒
1.
Iłecka J 《Journal of neural transmission (Vienna, Austria : 1996)》2004,111(2):167-172
Summary. The role of cyclic guanosine 5 monophosphate (cGMP) in neurodegeneration of motor neurons in amyotrophic lateral sclerosis (ALS) is still controversial. The aim of this study was to measure levels of cGMP in cerebrospinal fluid (CSF) of patients with ALS, and to investigate whether there is a relationship between CSF cGMP levels and clinical parameters of the disease. The study involved 30 ALS and 20 control group patients. The CSF cGMP was measured by the enzyme-linked immunosorbent assay. The results showed that levels of CSF cGMP were significantly decreased in the group of ALS patients compared to controls and did not depend on clinical state of ALS patients, type of ALS onset, or the duration of the disease. Decreased levels of CSF cGMP observed in this study may suggest the role of cGMP in neurodegeneration in ALS. The CSF cGMP cannot be a marker of the disease activity. 相似文献
2.
Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis 总被引:1,自引:0,他引:1
Lack of growth factors and hypoxia are two recent hypotheses about mechanisms underlying motor neuron death in amyotrophic lateral sclerosis. With this background, serum from 15 patients with amyotrophic lateral sclerosis and 15 controls, and CSF from 15 patients and 10 controls were analysed for fibroblast growth factor 2 (FGF-2) using an immunoassay. Serum FGF-2 levels were higher in the patient group than in the control group. FGF-2 was detected in CSF in 11/15 patients, but in none of the 10 control subjects. There were no correlations between age, duration of disease or clinical rating and FGF-2 levels. The findings indicate that FGF-2 is involved in the pathophysiological chain of events in this disorder. 相似文献
3.
Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis 总被引:1,自引:0,他引:1
Kasai T Tokuda T Ishigami N Sasayama H Foulds P Mitchell DJ Mann DM Allsop D Nakagawa M 《Acta neuropathologica》2009,117(1):55-62
There is mounting pathological, biochemical and genetic evidence that the metabolism and aggregation of the 43-kDa transactive
response (TAR)-DNA-binding protein (TDP-43) play a crucial role in the pathogenesis of sporadic and some forms of familial
amyotrophic lateral sclerosis (ALS). Recently, it was reported using an ELISA system that elevated levels of TDP-43 were detected
in plasma samples from patients with Alzheimer’s disease and frontotemporal dementia, compared to healthy controls. To determine
whether quantification of TDP-43 in cerebrospinal fluid (CSF) is potentially informative in the diagnosis of ALS, we measured
the concentration, by a similar ELISA method, of TDP-43 in CSF from 30 patients with ALS (diagnosed according to the revised
El Escorial criteria) and 29 age-matched control patients without any neurodegenerative disease. We found that, as a group,
the ALS patients had significantly higher levels of TDP-43 in their CSF than the age-matched controls (6.92 ± 3.71 ng/ml in
ALS versus 5.31 ± 0.94 ng/ml in controls, p < 0.05), with levels of TDP-43 in CSF elevated beyond 95% upper confidence level for the control group in six (20%) of the
patients with sporadic ALS. All the six patients with higher levels of CSF TDP-43 were examined within 10 months of the onset
of illness. The patients examined within 10 months of onset showed significantly higher levels of CSF TDP-43 (8.24 ± 4.72 ng/ml)
than those examined after 11 months or more of onset (5.41 ± 0.66 ng/ml, p < 0.05). These results suggest that the levels of TDP-43 in CSF may increase in the early stage of ALS. We also confirmed
the existence of the TDP-43 protein in CSF from some patients with ALS, and a control subject, by western blotting of proteins
immunocaptured from the CSF samples. Raised TDP-43 levels in the CSF may preempt the formation of TDP-43 pathology in the
central nervous system, or correlate with early-stage TDP-43 pathology, and accordingly be a biomarker for the early stage
of ALS. 相似文献
4.
Taskiran D Sagduyu A Yüceyar N Kutay FZ Pögün S 《The International journal of neuroscience》2000,101(1-4):65-72
Abnormal glutamate metabolism is implied in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS) and cerebrospinal fluid (CSF) glutamate levels appear to be elevated. Since nitric oxide (NO) inhibits glutamate transport, excessive amounts of nitric oxide could underlie the glutamate induced neurotoxicity in ALS. Stable metabolites of NO (NO2- + NO3-) levels were determined in serum and CSF of sporadic ALS patients and control subjects. NO2- + NO3- levels were higher in ALS, in males and in serum samples compared to controls, females and CSF, respectively. Furthermore, while the difference between serum and CSF NO2- + NO3- levels was significant in males (higher in serum) no such difference was observed in females. Our results suggest that nitric oxide may be involved in the pathogenesis of ALS directly or indirectly and in a sexually dimorphic manner. 相似文献
5.
Kawajiri M Mogi M Higaki N Tateishi T Ohyagi Y Horiuchi M Miki T Kira JI 《Acta neurologica Scandinavica》2009,119(5):341-344
Background – Recent studies suggest that angiotensin II, a major substrate in the renin–angiotensin system, protects neurons through stimulation of its type 2 receptors. However, quite a few clinical studies of angiotensin II levels have shown their relation to disease severity in neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS). Aims of the study – To clarify the significance of angiotensin II in ALS. Methods – We assayed angiotensin II concentrations in cerebrospinal fluid (CSF) samples from 23 patients with ALS, nine patients with spinocerebellar degeneration (SCD) and 24 control individuals. We evaluated the disability levels of patients with ALS using the Revised ALS Functional Rating Scale (ALSFRS‐R) and calculated the disease progression rate (DPR). Results – CSF angiotensin II levels were significantly lower in the ALS group compared with that in the control group (P = 0.00864), and showed a significant positive correlation with scores on the ALSFRS‐R, and a significant negative correlation with the DPR. Conclusions – In the present study, we reveal for the first time that angiotensin II levels in the CSF from patients with ALS are significantly reduced and significantly associated with disease severity and progression rate. These findings suggest that reduced levels of intrathecal angiotensin II may play a role in ALS. 相似文献
6.
7.
Jiménez-Jiménez FJ Hernánz A Medina-Acebrón S de Bustos F Zurdo JM Alonso H Puertas I Barcenilla B Sayed Y Cabrera-Valdivia F 《Acta neurologica Scandinavica》2005,111(2):114-117
OBJECTIVE: To elucidate whether cerebrospinal fluid (CSF) concentrations of the microtubule-associated tau protein are related to the risk for sporadic amyotrophic lateral sclerosis (SALS). PATIENTS/METHODS: We measured tau concentrations in the CSF of 18 patients with SALS and 75 age- and sex-matched controls, using a specific ELISA method. RESULTS: The mean CSF concentrations of tau protein did not differ significantly between SALS patient and control groups, were not influenced by the clinical form (spinal vs bulbar) of ALS, and were not correlated with age, age at onset, and duration of the disease. CONCLUSIONS: CSF tau concentrations are not a biochemical marker of ALS. 相似文献
8.
目的探讨肌萎缩侧索硬化(ALS)患者的脑脊液蛋白、髓鞘碱性蛋白(MBP)水平及脑脊液蛋白与临床特征之间的关系。方法回顾性研究行腰穿查脑脊液的29例确诊ALS患者,检测其脑脊液蛋白及MBP水平,并按性别、年龄、病程、起病部位及临床功能评分〔肌萎缩侧索硬化功能分级量表(ALS-FRS)评分〕等不同临床特征分组,分析不同临床特征对脑脊液蛋白水平的影响。结果 29例ALS患者脑脊液蛋白水平为(0.43±0.15)g/L,其中脑脊液蛋白轻度增高患者9例(31%),最高为0.89g/L;不同性别〔男(0.42±0.15)g/L,女(0.45±0.18)g/L,t=0.501,P=0.620〕、年龄〔60岁组(0.43±0.17)g/L,≥60岁(0.44±0.13)g/L,t=0.141,P=0.889〕、病程〔1年组(0.37±0.11)g/L,≥1年(0.49±0.17)g/L,t=-2.23,P=0.054〕、起病部位〔球部起病组(0.38±0.11),肢体起病组(0.45±0.17),t=0.330,P=0.743〕、ALS-FRS评分〔30分组(0.42±0.16)g/L,≤30分组(0.44±0.16)g/L,t=0.092,P=0.928〕分组间比较,脑脊液蛋白水平差异均无统计学意义。29例患者中13例进行了脑脊液MBP检测,MBP水平(1.66±0.78)nmol/L,13例患者MBP水平均增高,最高达3.39nmol/L。MBP水平与脑脊液蛋白水平无相关性(R=0.198,P=0.517)。结论 ALS患者脑脊液蛋白增高多见。部分ALS患者脑脊液MBP水平增高,但与脑脊液蛋白水平无相关性。 相似文献
9.
P. Janik H. Kwiecinski B. Sokolowska I. Niebroj-Dobosz 《Journal of neural transmission (Vienna, Austria : 1996)》2010,117(3):343-347
Erythropoietin (EPO) acts as a neuroprotective factor and is upregulated after neuronal injury. It has been reported that
in cerebrospinal fluid (CSF) of amyotrophic lateral sclerosis (ALS) patients, the EPO concentration is decreased. In this
study, EPO levels in serum and CSF of 30 patients with ALS and in 15 controls, using an ELISA technique, were estimated. EPO
level in serum was decreased, especially in patients with bulbar onset ALS. A trend toward a progressive EPO decline with
the duration of the disease in the mild + moderate ALS cases was observed. In severe cases, a tendency towards a positive
correlation of EPO and duration of the disease was present. Serum EPO values were age related only in mild + moderate ALS
in patients below 40 years of age. In CSF, the EPO levels were significantly decreased. Lower EPO values in the bulbar onset
ALS when compared with the spinal onset ALS were present. The EPO decrease did not correlate with the severity and duration
of the disease. Age relation of the EPO level only in the mild + moderate ALS cases more than 40 years was present. Lack of
differences in EPO levels between patients with ALS of rapid and slow progression indicates that EPO concentration cannot
be used as a prognostic factor. Nevertheless, the decreased serum and CSF EPO concentration and the known EPO neuroprotective
action may indicate that EPO administration can be a new promising therapeutic approach in ALS. 相似文献
10.
The significance of trace elements in the aetiopathogenesis of ALS is still unknown. Magnesium plays an essential role in fundamental cellular reactions. The aim of this study was to estimate total magnesium concentration in serum and cerebrospinal fluid of ALS patients. 15 persons with ALS and 12 controls took part in the examination. Magnesium was determined by spectrophotometric atomic-absorption method. Total magnesium concentration in serum of ALS patients was statistically insignificant lower than in the control group, but in cerebrospinal fluid was it statistically insignificantly higher than in the control group. Outcomes of our own investigations do not show any essential role of magnesium in the aetiopathogenesis of ALS. 相似文献
11.
R. Glenn Smith Y. Kay Henry Mark P. Mattson Stanley H. Appel 《Annals of neurology》1998,44(4):696-699
A marker of lipid peroxidation 4-hydroxynonenal (HNE) was elevated in the cerebrospinal fluid (CSF) of a patient with sporadic amyotrophic lateral sclerosis (sALS) compared with that of most patients with other neurological diseases. Such elevations of HNE were sufficient to kill cyclic adenosine monophosphate (cAMP)-differentiated motor neuron hybrid cells in vitro, and anti-oxidants prevented this HNE-dependent cell death. These data suggest that oxidative stress and lipid peroxidation are associated with and may promote motor neuron degeneration in sALS. 相似文献
12.
Nicola Ticozzi Cinzia Tiloca Niccolò E. Mencacci Claudia Morelli Alberto Doretti Daniela Rusconi Claudia Colombrita Davide Sangalli Federico Verde Palma Finelli Stefano Messina Antonia Ratti Vincenzo Silani 《Journal of neurology》2013,260(1):85-92
In amyotrophic lateral sclerosis (ALS) cerebrospinal fluid (CSF) analysis is usually performed to exclude inflammatory processes of the central nervous system. Although in a small subset of patients an intrathecal synthesis of IgG is detectable, usually there is no clear explanation for this evidence. This study investigates the occurrence of oligoclonal bands (OCBs) in the CSF of a large series of ALS patients, attempting a correlation with genotype data. CSF was collected from 259 ALS patients. CSF parameters were measured according to standard procedures, and detection of OCBs performed by isoelectric focusing. The patients were screened for mutations in SOD1, FUS, TARDBP, ANG, OPTN, and C9ORF72. We observed the presence of OCBs in the CSF of 9/259 ALS patients (3.5 %), and of disease-associated mutations in 12 cases. OCBs were significantly more frequent in mutation carriers compared to the remaining cohort (3/12 vs 6/247; p < 0.01). Among patients with OCBs, two patients had the TARDBP p.A382T mutation (one of which in homozygous state), and one the ANG p.P-4S variant. Both patients carrying the p.A382T mutation had an atypical phenotype, one of them manifesting signs suggestive of a cerebellar involvement, and the other presenting neuroradiological findings suggestive of an inflammatory disorder of the central nervous system. Our results suggest that ALS patients with OCBs may harbor mutations in disease-causing genes. We speculate that mutations in both TARDBP and ANG genes may disrupt the blood–brain barrier (BBB), promoting local immune responses and neuroinflammation. The role of mutant TARDBP and ANG genes on BBB integrity of ALS patients warrants further investigation. 相似文献
13.
Summary Epidermal growth factor (EGF), a mitogenic peptide, is widely distributed within the brain and endocrine cells of the gastro-intestinal tract. Using EGF radioreceptor assay, the EGF level was measured in lumbar cerebrospinal fluid from five patients with amyotrophic lateral scerlosis (ALS) and seven patients with intervertebral disc disease as a control group. The patients with ALS showed reduced EGF levels to 662.4±207 pg/ml as compared with controls 1013±182.8 pg/ml (P<0.02). These results indicate a possible EGF involvement in the pathogenesis of ALS.This work is partially supported by M.Z. V/31 相似文献
14.
15.
J. Kuhle R. L. P. Lindberg A. Regeniter M. Mehling A. J. Steck L. Kappos A. Czaplinski 《European journal of neurology》2009,16(6):771-774
Background and purpose: Amyotrophic lateral sclerosis (ALS) is classically assumed to be a neurodegenerative disorder. Inflammation has been observed in CNS tissue in ALS patients. We investigated the expression and prognostic relevance of proinflammatory chemokines in ALS.
Methods: We analyzed nine chemokines, eotaxin, eotaxin-3, IL-8, IP-10, MCP-1, MCP-4, macrophage derived chemokine (MDC), macrophage inflammatory protein-1β (MIP-1β), and serum thymus and activation- regulated chemokine (TARC) in serum and cerebrospinal fluid (CSF) of 20 ALS- and 20 non-inflammatory neurological disease (NIND)-patients.
Results: MCP-1 and IL-8 levels in CSF in ALS were significantly higher than in NIND (1304 pg/ml vs. 1055 pg/ml, P = 0.013 and 22.7 pg/ml vs. 18.6 pg/ml, P = 0.035). The expression of MCP-1 and IL-8 were higher in CSF than in serum ( P < 0.001). There was a trend towards higher MCP-1 CSF levels in ALS patients with shorter time between first symptoms and diagnosis ( r = −0.407; P = 0.075).
Conclusions: We confirmed previous findings of increased MCP-1 levels in CSF of ALS patients. Furthermore, increased levels of IL-8 in CSF suggest a stimulation of a proinflammatory cytokine cascade after microglia activation. We found a tendency for higher MCP-1 values in patients with a shorter diagnostic delay, who are known to have also a shorter survival. This may suggest an association of higher MCP-1 levels with rapidly progressing disease. 相似文献
Methods: We analyzed nine chemokines, eotaxin, eotaxin-3, IL-8, IP-10, MCP-1, MCP-4, macrophage derived chemokine (MDC), macrophage inflammatory protein-1β (MIP-1β), and serum thymus and activation- regulated chemokine (TARC) in serum and cerebrospinal fluid (CSF) of 20 ALS- and 20 non-inflammatory neurological disease (NIND)-patients.
Results: MCP-1 and IL-8 levels in CSF in ALS were significantly higher than in NIND (1304 pg/ml vs. 1055 pg/ml, P = 0.013 and 22.7 pg/ml vs. 18.6 pg/ml, P = 0.035). The expression of MCP-1 and IL-8 were higher in CSF than in serum ( P < 0.001). There was a trend towards higher MCP-1 CSF levels in ALS patients with shorter time between first symptoms and diagnosis ( r = −0.407; P = 0.075).
Conclusions: We confirmed previous findings of increased MCP-1 levels in CSF of ALS patients. Furthermore, increased levels of IL-8 in CSF suggest a stimulation of a proinflammatory cytokine cascade after microglia activation. We found a tendency for higher MCP-1 values in patients with a shorter diagnostic delay, who are known to have also a shorter survival. This may suggest an association of higher MCP-1 levels with rapidly progressing disease. 相似文献
16.
In 15 patients with SLA and 15 with discopathy regarded as a control group the level of epidermal growth factor (EGF) was determined by radioreceptor assay in the serum and cerebrospinal fluid. The EFG level in the serum could not be determined by this method. In the CSF of SLA patients this level was 587.6 +/- 257.7 pg/ml and was significantly lower in relation to the control group in which it was 990.9 +/- 297.5 pg/ml. The authors discuss in this connection the role of EGF in SLA pathogenesis. 相似文献
17.
目的
探讨自由基氧化损伤在散发性肌萎缩侧索硬化的发病机制中有无作用.
方法 散发性肌萎缩侧索硬化病人15例,神经系统正常的外科手术腰麻病人20例,采集脑脊液后用高效液相色谱法进行检测分析.比较散发性肌萎缩侧索硬化病人和神经系统正常的受试者脑脊液中3-硝基酪氨酸、酪氨酸含量及3-硝基酪氨酸与酪氨酸比值.结果
散发性肌萎缩侧索硬化病人脑脊液中3-硝基酪氨酸含量及3-硝基酪氨酸与酪氨酸比值与对照组相比增高有显著性差异病人组与对照组脑脊液中3-硝基酪氨酸含量分别为(228.52±124.30)
nmol/L和(112.86±47.10) nmol/L,P<0.01;两组的3-硝基酪氨酸与酪氨酸比值分别为(7.60±4.38)×10-3和(3.19±1.20)
×10-3,P<0.01.结论
由过硝酸根介导的自由基氧化损伤在散发性肌萎缩侧索硬化的发病机制中具有重要作用. 相似文献
18.
19.
Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. 总被引:4,自引:0,他引:4
To investigate the significance of peroxynitrite-mediated oxidative damage in the pathogenesis of sporadic amyotrophic lateral sclerosis (SALS), the concentrations of 3-nitrotyrosine and tyrosine in the cerebrospinal fluid (CSF) of patients with SALS were determined. The concentration of 3-nitrotyrosine and the 3-nitrotyrosine/ tyrosine ratio in patients with SALS were approximately seven times those of controls. Thus, the present findings in living patients provide in vivo evidence for a possible role of peroxynitrite, a mediator of oxidative stress, and increased nitration of tyrosine residues in the pathogenesis of SALS. 相似文献
20.
Toyojiro Matsuishi Shinichiro Nagamitsu Yushiro Yamashita Yoshihiko Murakami Hirohisa Kato Akihiko Kimura Tetsuo Sakai Akihiko Kimura Alan K. Percy Hiroshi Shoji 《Annals of neurology》1997,42(6):978-981
To clarify the mechanism of brain and spinal cord impairment in Rett syndrome (RS), we measured the cerebrospinal fluid (CSF) levels of substance P in 20 patients with RS including 16 childhood patients and 4 adult patients. Findings were compared with those obtained in age-matched controls and diseased controls. The CSF level of substance P was significantly lower in patients with RS compared with controls. The alteration in the CSF level of substance P may be related to the neurological impairment, especially autonomic dysfunction, and neuropathological involvement of dorsal root ganglia and peripheral nerve observed in RS. 相似文献